Patent · US Active

Methods for culture and production of single cell populations of human embryonic stem cells

US7964402B2 · kind B2 · utility

46Cited by
4References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2007
Grant dateJun 21, 2011
Priority date
Expiry dateAug 18, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2509/00
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

We used Accutase™, a commercially available cell detachment solution, for single cell propagation of pluripotent hESCs. Unlike trypsin dissociation, Accutase treatment does not significantly affect the plating efficiency of hESC dissociation into single cells. Cultures dissociated with Accutase to single cells at each passage maintain a higher proportion of pluripotent cells as compared to collagenase-passaged hESCs. Accutase-treated hESCs can be grown to a high density as monolayers, and yet retain their pluripotency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.